[Nipiopharmacologic specialty. I. Nipiopharmacology from the obstetrical point of view].
D000700:Analgesics / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D001463:Barbiturates / Q000009:adverse effects; D003348:Cortisone / Q000009:adverse effects; D036861:Delivery, Obstetric; D004232:Diuretics / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects; D008431:Maternal-Fetal Exchange; D010121:Oxytocin / Q000009:adverse effects; D010276:Parasympatholytics / Q000009:adverse effects; D010372:Pediatrics; D011247:Pregnancy; D012110:Reserpine / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects; D014662:Vasoconstrictor Agents / Q000009:adverse effects; D014665:Vasodilator Agents / Q000009:adverse effects; D014815:Vitamins / Q000009:adverse effects
D000700:Analgesics; D000777:Anesthetics; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D001463:Barbiturates; D004232:Diuretics; D004967:Estrogens; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D013449:Sulfonamides; D014149:Tranquilizing Agents; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014815:Vitamins; D010121:Oxytocin; D012110:Reserpine; D003348:Cortisone
Nipiofarmacologia specialistica. I. Nipiofarmaciologia dal punto di vista ostetrico.